Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstatin, produced by MH435-hF3

J Antibiot (Tokyo). 1986 Jan;39(1):170-3. doi: 10.7164/antibiotics.39.170.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Actinomycetales / analysis
  • Antibiotics, Antineoplastic / analysis*
  • Antibiotics, Antineoplastic / pharmacology
  • Carcinoma, Squamous Cell / drug therapy
  • Cell Line
  • ErbB Receptors
  • Humans
  • Hydroquinones / analysis*
  • Hydroquinones / pharmacology
  • Microbial Sensitivity Tests
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Receptors, Cell Surface / metabolism*
  • Spectrophotometry, Infrared
  • Spectrophotometry, Ultraviolet

Substances

  • Antibiotics, Antineoplastic
  • Hydroquinones
  • Receptors, Cell Surface
  • ErbB Receptors
  • Protein-Tyrosine Kinases
  • erbstatin